CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 77 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $758,160 | +65.4% | 19,736 | -0.3% | 0.00% | – |
| Q1 2023 | $458,374 | +75.2% | 19,796 | +98.2% | 0.00% | – |
| Q4 2022 | $261,637 | +49.5% | 9,988 | -0.1% | 0.00% | – |
| Q2 2022 | $175,000 | -93.5% | 10,003 | -94.2% | 0.00% | -100.0% |
| Q1 2021 | $2,704,000 | -1.5% | 173,551 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,746,000 | – | 173,551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |